Midkine Dependent Immunosuppressive Environment in Cerebrospinal Fluid May Promote Leptomeningeal Metastases of EGFR mutant NSCLC

被引：0

作者：

Li, Y. -S. ^{[1
]}

Yin, K. ^{[1
]}

Lai, W. -P. ^{[2
]}

Zheng, M. -M. ^{[1
]}

Tu, H. -Y. ^{[1
]}

Wang, Z. ^{[1
]}

Zeng, L. ^{[1
]}

Jiang, B. -Y. ^{[1
]}

Yang, J. -J. ^{[1
]}

Zhou, Q. ^{[1
]}

Zhong, W. -Z. ^{[1
]}

Yang, X. -N. ^{[1
]}

Chen, H. -J. ^{[1
]}

Wu, Y. -L. ^{[1
]}

机构：

[1] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst,Guangdong Prov Key Lab, Guangzhou, Peoples R China

[2] Jinan Univ, Inst Hematol, Sch Med, Guangzhou, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

Leptomeningeal metastases; immunosuppressive environment; midkine;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.09-02

引用

页码：S199 / S200

页数：2

共 38 条

[31] Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases
Ruan, Haoyu
Wang, Zhe
Sun, Ziwei
Wei, Jia
Zhang, Lei
Ju, Huanyu
Wang, Ting
Zhang, Chao
Guan, Ming
Pan, Shiyang
CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (06):
[32] Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis
Chiang, Chi-Lu
Lee, Cheng-Chia
Huang, Hsu-Ching
Wu, Chia-Hung
Yeh, Yi-Chen
Shen, Chia-, I
Luo, Yung-Hung
Shiao, Tsu-Hui
Chang, Han Jhih
Huang, Yu-Ting
Chen, Yuh-Min
Chou, Teh-Ying
Chiu, Chao-Hua
TARGETED ONCOLOGY, 2021, 16 (02) : 207 - 214
[33] Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis
Chi-Lu Chiang
Cheng-Chia Lee
Hsu-Ching Huang
Chia-Hung Wu
Yi-Chen Yeh
Chia-I Shen
Yung-Hung Luo
Tsu-Hui Shiao
Han Jhih Chang
Yu-Ting Huang
Yuh-Min Chen
Teh-Ying Chou
Chao-Hua Chiu
Targeted Oncology, 2021, 16 : 207 - 214
[34] Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases
Wu, Xi
Xing, Puyuan
Shi, Min
Guo, Weihua
Zhao, Fangping
Zhu, Honglin
Xiao, Jianping
Wan, Jinghai
Li, Junling
FRONTIERS IN ONCOLOGY, 2022, 12
[35] Osimertinib for patients (pts) with leptomeningeal metastases (LM) from EGFR-mutant non-small cell lung cancer (NSCLC): Updated results from the BLOOM study.
Yang, James Chih-Hsin
Cho, Byoung Chul
Kim, Dong-Wan
Kim, Sang-We
Lee, Jong-Seok
Su, Wu-Chou
John, Tom
Kao, Stephen Chuan-Hao
Natale, Ronald
Goldman, Jonathan Wade
Overend, Philip
Vishwanathan, Karthick
Ye, Xin
Yang, Zhenfan
Ahn, Myung-Ju
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[36] Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases
Chiang, Chi-Lu
Ho, Hsiang-Ling
Yeh, Yi-Chen
Lee, Cheng-Chia
Huang, Hsu-Ching
Shen, Chia-, I
Luo, Yung-Hung
Chen, Yuh-Min
Chiu, Chao-Hua
Chou, Teh-Ying
THORACIC CANCER, 2023, 14 (14) : 1251 - 1259
[37] RETRACTED: Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with EGFR-Mutated Non-Small-Cell Lung Cancer Regardless of Cerebrospinal Fluid T790M Mutational Status (Retracted Article)
Zhang, Milan
Ma, Weifeng
Liu, Huiqin
Jiang, Yushu
Qin, Lingzhi
Li, Wei
Zhang, Jiewen
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[38] Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC-a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier: ChiCTR1800016615)
Fan, Chengjuan
Zhao, Qiuyu
Li, Li
Shen, Weixi
Du, Yang
Teng, Chong
Gao, Feng
Song, Xiaowei
Jiang, Qiuying
Huang, Dayong
Jin, Yinghua
Lv, Yanju
Wei, Lingxiao
Shi, Tengfei
Zhao, Xue
Gao, Naisheng
Jiang, Zhengjun
Xin, Tao
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (08) : 1359 - 1368

← 1 2 3 4 →